New Results
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
doi: https://doi.org/10.1101/2021.04.23.441075
Satoshi Imanishi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Lijuan Huang
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Shoko Itakura
2Graduate School of Biological Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Masamichi Ishizaka
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Tsukamoto
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Saito
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Yoichi Iwasaki
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Tomohiro Yamaguchi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Etsuko Miyamoto-Sato
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Posted April 23, 2021.
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)